Form 8-K - Current report:
SEC Accession No. 0001062993-15-001619
Filing Date
2015-03-30
Accepted
2015-03-30 17:17:51
Documents
4
Period of Report
2015-03-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 13943
2 EXHIBIT 3.1 exhibit3-1.htm EX-3.1 6080
3 GRAPHIC exhibit3-1x1x1.jpg GRAPHIC 3353
4 GRAPHIC exhibit3-1x1x2.jpg GRAPHIC 2925
  Complete submission text file 0001062993-15-001619.txt   30335
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-51652 | Film No.: 15735467
SIC: 8731 Services-Commercial Physical & Biological Research